SUBSCRIBE
SUBSCRIBE

Phase 1

For Sale: Pfizer's $3.4 Billion Consumer Healthcare Business
Drug Development
4 Clinical Projects Shelved From Pfizer’s Pipeline
August 2, 2017
 · 
2 min read
Why This Biotech, Up 300% Since May, Could be the Next Big M&A Target
Drug Development
Massachusetts’ Homology Medicines Snags $83.5M to Advance AMEnDR into Human Trials
August 1, 2017
 · 
2 min read
Ex-Akebia Director Re-arrested After Insider Trading Prosecutors Call Him Unhinged
Drug Development
Following Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study
July 31, 2017
 · 
2 min read
Roche Slammed With Partial Holds for Two Combo Cancer Trials
Drug Development
FDA Calls Roche’s Leukemia Drug a Breakthrough
July 28, 2017
 · 
2 min read
Drug Development
Drinking Alcohol After Studying Can Improve Memory, Scientific Reports Reveals
July 27, 2017
 · 
1 min read
Drug Development
Amgen Falls After Earnings Update Reveals Embarassingly ‘Bare’ Pipeline
July 26, 2017
 · 
2 min read
How Eli Lilly Allegedly Used a Fake Rule and Fake News to Protect Bad Patents
Drug Development
Eli Lilly Shakes Up Cancer R&D Strategy, Seeks New Home for Seven Pipeline Drugs
July 25, 2017
 · 
3 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
5 Biotechs With $45 Billion Worth of Not-Yet Approved Drugs in the Pipeline
July 24, 2017
 · 
3 min read
3 Biotechs That Could be Taken Out This Quarter
Drug Development
2 Tiny Cancer Biotechs That Could Gain Steam by Year-End
July 24, 2017
 · 
3 min read
10 Biotechs Tackling Senator John McCain's Form of Aggressive Brain Cancer
Drug Development
10 Biotechs Tackling Senator John McCain’s Form of Aggressive Brain Cancer
July 21, 2017
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE034, a Potential First-In-Class B7H3/PTK7 Bispecific TOP1 ADC
February 25, 2026
 · 
5 min read
Press Releases
Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)
February 25, 2026
 · 
8 min read
Press Releases
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
February 25, 2026
 · 
7 min read
Press Releases
Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
February 25, 2026
 · 
6 min read
Press Releases
Vico Therapeutics Announces Patient Dosing in Twice-Annual Regimen of VO659 in Phase 1/2 Trial in Huntington’s Disease, Spinocerebellar Ataxia Type 3 and Type 1
February 24, 2026
 · 
3 min read
Press Releases
Cartography Biosciences Doses First Patient in Phase 1 Trial of CBI-1214, a Highly Specific T-Cell Engager for the Treatment of Colorectal Cancer
February 24, 2026
 · 
4 min read
Press Releases
AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics’ Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01)
February 24, 2026
 · 
4 min read
Press Releases
Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)
February 24, 2026
 · 
4 min read
Press Releases
Monte Rosa Therapeutics Presents Updated Clinical Data from Phase 1/2 Study of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients at ASCO Genitourinary Cancers Symposium (ASCO GU)
February 24, 2026
 · 
10 min read
Press Releases
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor
February 24, 2026
 · 
6 min read
Press Releases
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
February 24, 2026
 · 
11 min read
Press Releases
Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Patients with Asthma with its Novel Bispecific Anti-TSLP/IL-4Rα Antibody ATI-052
February 24, 2026
 · 
5 min read
Press Releases
Centauri Therapeutics Extends Series A to £30M With £6M Investment From AMR Action Fund to Support Progression of Lead Clinical Candidate
February 24, 2026
 · 
3 min read
Press Releases
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
February 24, 2026
 · 
20 min read
Press Releases
Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
February 24, 2026
 · 
10 min read
Press Releases
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
February 24, 2026
 · 
9 min read
Press Releases
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
February 24, 2026
 · 
11 min read
Press Releases
Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026
February 23, 2026
 · 
7 min read
Press Releases
Benitec Biopharma Announces Acceptance of Late- Breaking Abstract for the BB-301 Phase 1b/2a Clinical Treatment Study at the Muscular Dystrophy Association Clinical & Scientific Conference
February 23, 2026
 · 
6 min read
Press Releases
Opterion Health AG Announces First Patient enrolled in Phase 1 SPARC Trial Following CTA Approval for OPT101
February 23, 2026
 · 
2 min read
Load More